TROP2-Targeting Antibody-Drug Conjugates

The expert panel discusses TROP2 as a target for patients with cancer who are receiving antibody-drug conjugates.

Related Keywords

,Targeting Antibody Drug ,Antibody Drug Conjugates ,Sadc ,Trop2 ,Breast Cancer ,Sacituzumab Govitecan ,Triple Negative Breast Cancer ,Ther2 ,Ascent Trial ,Trop2 Adc ,Dato Dxd ,Lung Cancer ,Adverse Effects ,Toxicity ,